|
Video: What is a Stock Split?
|
|
Ocugen is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Co. develops, manufactures, and commercializes COVAXIN for the prevention of COVID-19. Co.'s gene therapy candidate, OCU400 is for the treatment of certain disease genotypes: nuclear receptor subfamily 2 group E member 3, centrosomal protein 290, rhodopsin, and phosphodiesterase 6B mutation-associated inherited retinal degenerations. Co.'s second gene therapy candidate, OCU410, is being developed to utilize the nuclear receptor genes RAR-related orphan receptor A for the treatment of dry age-related macular degeneration. According to our Ocugen stock split history records, Ocugen has had 1 split. | |
|
Ocugen (OCGN) has 1 split in our Ocugen stock split history database. The split for OCGN took place on September 30, 2019. This was a 1 for 60 reverse split, meaning for each 60 shares of OCGN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 16.6666666666667 share position following the split.
When a company such as Ocugen conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Ocugen stock split history from start to finish, an original position size of 1000 shares would have turned into 16.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ocugen shares, starting with a $10,000 purchase of OCGN, presented on a split-history-adjusted basis factoring in the complete Ocugen stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/30/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$636.60 |
|
End price/share: |
$1.78 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.72% |
|
Average Annual Total Return: |
-47.06% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$27.97 |
|
Years: |
9.24 |
|
|
|
Date |
Ratio |
09/30/2019 | 1 for 60 |
|
|